Detalhe da pesquisa
1.
Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis.
Cephalalgia
; 44(2): 3331024241235156, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410850
2.
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
Cephalalgia
; 51(8): 3331024231190296, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37638400
3.
Harassment in the headache field: a global web-based cross-sectional survey.
Cephalalgia
; 43(8): 3331024231193099, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652444
4.
A qualitative evidence synthesis of patient perspectives on migraine treatment features and outcomes.
Headache
; 63(2): 185-201, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602191
5.
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing-off of erenumab within monthly treatment cycle.
Headache
; 63(2): 233-242, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226464
6.
Migraine: integrated approaches to clinical management and emerging treatments.
Lancet
; 397(10283): 1505-1518, 2021 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773612
7.
Perceived barriers to career progression in the headache field: A global web-based cross-sectional survey.
Cephalalgia
; 42(14): 1498-1509, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071614
8.
Acute Treatment of Headache (Focus on Migraine).
Semin Neurol
; 42(4): 494-502, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323302
9.
Narrative review of neuroimaging in migraine with aura.
Headache
; 61(9): 1324-1333, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309848
10.
Grand rounds education in neurology, with a focus on headache medicine.
Headache
; 61(7): 1077-1085, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990947
11.
Patient experience of telemedicine for headache care during the COVID-19 pandemic: An American Migraine Foundation survey study.
Headache
; 61(5): 734-739, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021595
12.
Dehydration and Headache.
Curr Pain Headache Rep
; 25(8): 56, 2021 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34268642
13.
Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.
JAMA
; 325(23): 2357-2369, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34128998
14.
Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.
Headache
; 60(5): 833-842, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32227596
15.
Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study.
Headache
; 60(10): 2444-2453, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179323
16.
Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II.
Headache
; 60(4): 686-700, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073660
17.
Ten Eleven Things Not to Say to Healthcare Professionals During the Coronavirus Disease 2019 Pandemic.
Headache
; 60(8): 1837-1845, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32696455
18.
COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.
Headache
; 60(8): 1558-1568, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32648592
19.
Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.
Cephalalgia
; 39(1): 52-60, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722276
20.
Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine.
Cephalalgia
; 39(12): 1569-1576, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31266353